echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Lifting the daily average price limit will help low-cost drug coverage

    Lifting the daily average price limit will help low-cost drug coverage

    • Last Update: 2020-05-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In recent years, a number of policies to support low-cost drugs have been introducedThe establishment of a normal reserve mechanism for shortage drugs, the dynamic monitoring of shortage drugs, the mass release of low-cost shortage drug information on the national drug supply guarantee information platform, and the targeted production and centralized supply of some low-cost drugs all play a role in ensuring the supply of low-cost drugsAmong them, in May 2014, the National Development and Reform Commission (NDRC) abolished the maximum retail price limit for more than 500 low-priced drugs, which is considered an extremely important measure to support low-cost drugsbut at the same time to liberalize the highest retail price of low-cost drugs, there are certain conditionsFor example, only in the Western medicine costs no more than 3 yuan a day, the average daily price of traditional Chinese medicine does not exceed 5 yuan, the premise that enterprises can set their own pricesIt is perfectly understandable that the pace of liberalizing the highest retail price of low-cost drugs is a bit more cautiousHowever, we should also see that the average daily cost ceiling not only limits unreasonable price increases, but also limits reasonable profit marginsEspecially when the price of raw materials, labor costs and other aspects of a relatively large increase, the profit margin of low-cost drugs become smaller and smaller, the average daily cost ceiling on low-cost drugs more obvious impactThis has also led to frequent shortages of low-cost drugscan be considered that the abolition of the average daily cost of low-cost drugs, is not only the current situation of development of a necessity, but also reflects the ability of market regulation of a kind of trustWithout this qualification, pharmaceutical companies can adjust prices in accordance with market laws, which may help to resolve the shortage of low-cost drugs as soon as possiblebut also to see that the abolition of low-cost drug daily average price limit is also a double-edged sword, in the mobilization of pharmaceutical companies production enthusiasm at the same time, can not rule out the irrational rise in pricesTherefore, at the same time of liberalization, to be more sophisticated and complete monitoring as a supplementWhen the market in accordance with its own laws when price fluctuations, should be bold to let the market to achieve self-regulation, and when the non-market behavior of the phenomenon of price hikes or collusive price increases, supervision should be decisive to maintain the normal order of the pharmaceutical market.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.